Gates Package — page 114
of 1375 pages
← p.113 p.115 → · this page in the original PDF · package
From: "Handley, Gray (NIH/NIAID) [E]" <{B@niaid
nih. gov>
To: "Varmus, Harold (NIH/NCI) [E]" <EOnih.gov>
Ce: "Fauci, Anthony (NIH/NIAID) [E]" <{ifniaid.nih.gov>, "Auchincloss, Hugh
(NIH/NIAID) [E]" <Q
Oniaid.nih.gov>, "Zoon, Kathryn (NIH/NIAID) [E]"
)niaid.nih.gov>, "Pineda, Mark (NIH/NIAID) [E]"
@niaid.nih.gov>,
"Hedje, Judith (NIH/NIAID) [E]" <{if@niaid.nih.gov>
Subject: RE: MRTC in Bamako
Date: Thu, 11 Apr 2013 14:11:52 -0400
Importance: Normal
Attachments: History NIAID_USTTB_collaboration_11_Apr_2013.docx;
Gates_Foundation_Call_for_Global_Health_Case_Studies_11_28
08 gh edits_no_tracked_
changes-map.doc;
LABORATORY_CAPACITY_AND_INFRASTRUCTURE_April2013.doc
Dr. Varmus:
Attached is background information on the ICER in Mali.
I am sending what I have gathered so far -- two documents
prepared for different purposes, which describe this long-term engagement. So far, I am still pulling together information
about overall funding, although the "History" piece includes some recent information. Gathering this data is challenging
because much of the early support was from a variety of sources including Foundations and USAID. I will send at least a
ball-park figure next week,
Yesterday, the ICER programs all presented on their current studies so I will also try to share the slides related to the Mali
program. These well illustrated some aspects of the history and the current breadth of our scientific engagement there.
I have also attached a short paper on our ICER in Uganda. Another very productive partnership where many sources of
funding have helped build a robust infrastructure used by both extramural and intramural scientists. We also have an
NIAID scientist posted there to oversee this program.
On the Lahore involvement, I was able to learn a little of the back-story from Dr. Karl Western, our knowledgeable
historian. From 1959-1981 the University of Maryland, Baltimore had an International Center for Medical Research (and
Training) [ICMR(T)] in Lahore, Pakistan. This program was one of NIAID's earliest tools to help build research capacity
overseas. When the International Centers for Infectious Disease Research (ICIDR) program was competed for the first
time (it was envisioned as a replacement for the ICMR(T)), none of the ICMR's were competitive and so funding was slated
to end for the Lahore program. The UMd Dean and US PI for the Lahore ICMR(T) visited NIAID with a Maryland
Congressional Delegation to seek reversal of the decision not to fund Lahore as an ICIDR. This was about the time that the
Soviets invaded Afghanistan so the State Department was eager not to have anything offend Pakistan (sounds familiar).
The compromise was for UMd to submit the best components of their ICIDR application as individual RO1 applications.
One got funded but then later did not re-compete successfully; so the UMd ICMR faded out.
On PEPFAR, I would be happy to share my point of view about how NIH researchers formed the foundation for early
PEPFAR success, particularly in South Africa and Uganda, if that would be helpful at some point.
Hope this is useful; more to come.
Gray
From: Varmus, Harold (NIH/NCI) [E]
Sent: Monday, April 08, 2013 5:20 PM
This is our OCR of the page, with running headers and footers removed. The
Committee's PDF
is authoritative; quote from it. Machine-readable, including the uncleaned
text: /api/page/gates/114
Records on this page
| Record | Date | Type | Pages |
|---|---|---|---|
| gates:exh:00041 | — | attachment | 114 |
| Re: MRTC in Bamako | 2013-04-08 | 114–115 |